中华内分泌外科杂志
中華內分泌外科雜誌
중화내분비외과잡지
CHINESE JOURNAL OF ENDOCRINE SURGERY
2014年
3期
227-229
,共3页
张颖辉%秦贵军%王冰%李俊%闫昱杉%余勤%董义光
張穎輝%秦貴軍%王冰%李俊%閆昱杉%餘勤%董義光
장영휘%진귀군%왕빙%리준%염욱삼%여근%동의광
桥本甲状腺炎%糖皮质激素%左旋甲状腺素
橋本甲狀腺炎%糖皮質激素%左鏇甲狀腺素
교본갑상선염%당피질격소%좌선갑상선소
Hashimoto thyroiditis%Glucocorticoid%Levothyroxine
目的 观察糖皮质激素冲击治疗桥本甲状腺炎(hashimoto thyroiditis,HT)伴甲状腺肿大的疗效.方法 收集郑州大学第一附属医院内分泌科住院确诊的HT 30例,均口服优甲乐,维持FT3、FT4及TSH水平在正常参考值范围3个月后,甲状腺肿大仍较明显,应用甲基强的松龙每次250 mg,每日1次,共7次,后改为口服强的松片10 mg,每日3次,每周减5 mg至停药,共6周.激素冲击治疗前后行甲状腺B超检测.结果 激素冲击治疗后甲状腺左右叶长、宽、厚及峡部明显缩小(P<0.05),左叶治疗前后长分别为(57.42±12.87)~(46.37±7.67) mm,t =4.58;宽(26.68 ±7.71) ~ (22.21±6.09) mm,t=4.56;厚(27.18 ±6.60)~(21.14 ±5.67)mm,t =7.28;右叶治疗前后长分别为(58.17±12.32)~(49.73±9.35)mm,t=3.84;宽(26.14 ±7.37)~(23.00 ±6.68)ram,t=3.29;厚(27.57 ±6.42)~ (22.00 ±5.55)mm,=5.88;峡部治疗前后分别为(9.94 ±4.15) ~ (6.19±2.57) mm,t=6.09.1年后随访复发率17%(5/30).结论 糖皮质激素冲击治疗桥本甲状腺炎并甲状腺肿大疗效显著,复发率低.
目的 觀察糖皮質激素遲擊治療橋本甲狀腺炎(hashimoto thyroiditis,HT)伴甲狀腺腫大的療效.方法 收集鄭州大學第一附屬醫院內分泌科住院確診的HT 30例,均口服優甲樂,維持FT3、FT4及TSH水平在正常參攷值範圍3箇月後,甲狀腺腫大仍較明顯,應用甲基彊的鬆龍每次250 mg,每日1次,共7次,後改為口服彊的鬆片10 mg,每日3次,每週減5 mg至停藥,共6週.激素遲擊治療前後行甲狀腺B超檢測.結果 激素遲擊治療後甲狀腺左右葉長、寬、厚及峽部明顯縮小(P<0.05),左葉治療前後長分彆為(57.42±12.87)~(46.37±7.67) mm,t =4.58;寬(26.68 ±7.71) ~ (22.21±6.09) mm,t=4.56;厚(27.18 ±6.60)~(21.14 ±5.67)mm,t =7.28;右葉治療前後長分彆為(58.17±12.32)~(49.73±9.35)mm,t=3.84;寬(26.14 ±7.37)~(23.00 ±6.68)ram,t=3.29;厚(27.57 ±6.42)~ (22.00 ±5.55)mm,=5.88;峽部治療前後分彆為(9.94 ±4.15) ~ (6.19±2.57) mm,t=6.09.1年後隨訪複髮率17%(5/30).結論 糖皮質激素遲擊治療橋本甲狀腺炎併甲狀腺腫大療效顯著,複髮率低.
목적 관찰당피질격소충격치료교본갑상선염(hashimoto thyroiditis,HT)반갑상선종대적료효.방법 수집정주대학제일부속의원내분비과주원학진적HT 30례,균구복우갑악,유지FT3、FT4급TSH수평재정상삼고치범위3개월후,갑상선종대잉교명현,응용갑기강적송룡매차250 mg,매일1차,공7차,후개위구복강적송편10 mg,매일3차,매주감5 mg지정약,공6주.격소충격치료전후행갑상선B초검측.결과 격소충격치료후갑상선좌우협장、관、후급협부명현축소(P<0.05),좌협치료전후장분별위(57.42±12.87)~(46.37±7.67) mm,t =4.58;관(26.68 ±7.71) ~ (22.21±6.09) mm,t=4.56;후(27.18 ±6.60)~(21.14 ±5.67)mm,t =7.28;우협치료전후장분별위(58.17±12.32)~(49.73±9.35)mm,t=3.84;관(26.14 ±7.37)~(23.00 ±6.68)ram,t=3.29;후(27.57 ±6.42)~ (22.00 ±5.55)mm,=5.88;협부치료전후분별위(9.94 ±4.15) ~ (6.19±2.57) mm,t=6.09.1년후수방복발솔17%(5/30).결론 당피질격소충격치료교본갑상선염병갑상선종대료효현저,복발솔저.
Objective To assess the efficacy of methylprednisolone (MP)pulse therapy in treatment of Hashimoto thyroiditis(HT) complicated with goiter.Methods 30 patients with HT complicated with goiter participated in the study and received MP pulse therapy.The patients had to be euthyroid for at least 3 months before the date of inclusion with plasma concentrations of thyroid hormones within their reference range.The goiter was still obvious and had no improvement.A dose of 250 mg MP was administered intravenously for seven consecutive days,and then treated with oral prednisone 10 mg,three times per day for 6 weeks with the dosage in each week gradually reduced at 5 mg to none.Ultrasonic was used to measure thyroid size before and after MP treatment.Results The treatment was successful at the end of the trial in all of the 30 patients receiving MP.The thyroid size from length,breadth,thickness to isthmus obviously decreased (P < 0.05).The length of the left lobe was (57.42 ± 12.87) mm and (46.37 ± 7.67) mm (t =4.58) before and after treatment; The breadth of the left lobe was(26.68 ±7.71) mm and(22.21 ±6.09) mm(t =4.56) before and after treatment; The thickness of the left lobe was (27.18 ± 6.60) mm and (21.14 ± 5.67) mm(t =7.28) before and after treatment.The length of the right lobe was(58.17 ± 12.32)mm and(49.73 ±9.35) mm(t =3.84) before and after treatment; The breadth of the right lobe was (26.14 ± 7.37)mm and (23.00 ± 6.68) mm(t =3.29) before and after treatment ; The thickness of the right lobe was(27.57 ± 6.42)mm and(22.00 ±5.55)(t =5.88)before and after treatment.The isthmus before and after treatment was(9.94 ±4.15)mm and(6.19 ±2.57)mm(t =6.09).The recurrence rate was 17% (5/30) after one year.Conclusions MP pulse therapy is an effective treatment for HT complicated with goiter.The recurrence rate is low.